ArticleAdvanced science (Weinheim, Baden-Wurttemberg, Germany)2022

Engineering ROS-Responsive Bioscaffolds for Disrupting Myeloid Cell-Driven Immunosuppressive Niche to Enhance PD-L1 Blockade-Based Postablative Immunotherapy.

Shaoyue Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.